Frezyderm Ac-norm Medilike Ef.type1 50ml.

Frezyderm AC-NORM Medilike Effect 1 Cream 50ml

Targeted Medical Device for Mild Comedonal Acne

Frezyderm AC-NORM Medilike Effect 1 Cream 50ml is a specialised topical medical device developed for mild comedonal acne. Designed for acne-prone skin, it provides targeted care for concerns associated with blocked pores and the formation of comedones. Its controlled-release formulation is intended to support the management of mild acne through the action of slow-release salicylic acid.

Mild comedonal acne commonly appears as blackheads, whiteheads and small blemishes caused by the accumulation of dead skin cells and sebum within hair follicles. Frezyderm AC-NORM Medilike Effect 1 is specifically positioned for Type 1 acne, distinguishing it from the Medilike Effect 2 and Effect 3 formulations intended for moderate and severe inflammatory acne, respectively.

The formula contains slow-release salicylic acid, an ingredient known for its keratolytic properties. It helps loosen accumulated dead skin cells and supports the management of blocked pores. According to the supplied product information, the formulation uses an osmotically controlled delivery mechanism to provide gradual action on comedones, papules and pustules.

As part of the Frezyderm AC-NORM range, this cream offers a targeted approach to mild acne rather than general moisturising or everyday cleansing. Its intended application to affected areas makes it suitable for a focused skincare routine when used according to the manufacturer's instructions.

The product is classified as a medical device and is intended for external use only. Apply to the affected area once or twice daily, depending on the individual case, for up to 30 days. Do not use the product if you are allergic to any ingredient or if it has passed its expiry date. Avoid contact with the eyes and mucous membranes, store between 15°C and 25°C, and keep out of reach of children.

Frezyderm AC-NORM Medilike Effect 1 is dermatologically tested. Although the supplied UK product information states that there are no contraindications, users should still read the complete instructions before application. Seek advice from a healthcare professional if acne persists, worsens or causes scarring.

Key Features

• Topical medical device intended for mild comedonal acne

• Specifically positioned for Type 1 acne

• Contains slow-release salicylic acid

• Uses an osmotically controlled delivery mechanism

• Dermatologically tested formulation for targeted application

Key Benefits

• Supports the management of mild comedonal acne

• Helps loosen dead skin cells that can contribute to blocked pores

• Provides targeted care for comedones and other acne lesions

• Offers controlled delivery of salicylic acid to affected areas

• Complements an appropriate acne-care routine when used as directed

Key Ingredients

Slow-Release Salicylic Acid: A keratolytic ingredient that helps loosen accumulated dead skin cells and supports the management of blocked pores and comedones.

Osmotically Controlled Delivery System: The formulation is designed to release active ingredients gradually, supporting targeted action on acne-affected areas.

The complete INCI ingredient list and salicylic acid concentration should be confirmed against the product packaging before publication.

How to Use

Apply Frezyderm AC-NORM Medilike Effect 1 Cream directly to the affected area according to the manufacturer's instructions.

• Frequency: Once or twice daily, depending on the individual case.

• Duration: Use for up to 30 days.

• Application: Apply only to the intended affected areas.

• Precautions: For external use only. Avoid the eyes and mucous membranes.

• Storage: Keep between 15°C and 25°C, away from children.

Do not use if you have an allergy to any ingredient or if the product has expired. Consult a doctor, dermatologist or pharmacist if you are unsure whether this product is appropriate for your skin.

Formulated Without / Formulation Information

• Classified as a medical device

• Contains slow-release salicylic acid

• Uses an osmotically controlled delivery mechanism

• Dermatologically tested

• Intended for a defined course of up to 30 days

No additional claims about being fragrance-free, alcohol-free, paraben-free or free from other ingredients have been verified.